All trials - page: 235

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT03567213Investigation on the Cortical Communication (CortiCom) SystemJohns Hopkins UniversitySingle Group Assignment
  • Age 22 - 70 yrs
  • Level C1-C8
  • AIS A, B, C, D
  • ≥ 1 years
  • NOT have implanted devices incompatible with MRI
Recruiting3Not ApplicableSurgeryGeneral health26 weeks14 December 202125 June 20181
NCT05622994Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord InjuryHospital Nacional de Parapléjicos de Toledo
  • Age 18 - 75 yrs
  • Level C4-L1
  • AIS C, D
  • ≥ 1 years
  • NOT have severe bone, kidney, or liver dysfunction
  • NOT have hypothyroidism
80PHASE2DrugGeneral health
  • 10 Meter Walking Test (10 MWT)
  • 6-Minute Walk Test (6MWT)
  • Ashworth and Modified Ashworth Scale (MAS)
  • European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L)
  • Fatigue Severity Scale (FSS)
  • Hospital Anxiety and Depression Scale (HADS)
  • Numeric Pain Rating Scale
  • Penn Spasm Frequency Scale (PSFS)
  • Spinal Cord Independence Measure (SCIM)
120 days01 November 202221 November 20221
NCT05757830PURO - PUlmonary Rehabilitation With O-RAGT PlatformFondazione Don Carlo Gnocchi Onlus
  • Age 18 - 90 yrs
  • Level T2-S5
  • AIS B, C, D
  • All
  • Able to use a walker.
Ended20NATechnologyStanding/walking/mobility
  • 2 Minute Walk Test
48 hours23 December 202207 March 20234
NCT05646810Impact of Peripheral Afferent Input on Central Neuropathic PainUniversity of Aarhus
  • Age 18 - 80 yrs
  • Level C1-T12
  • AIS A, B, C, D
  • ≥ 1 years
20NADrugPain
  • Numeric Pain Rating Scale
95 minutes01 December 202212 December 20220
NCT05705453Epidural Stimulation After Neurologic Damage: Long-Term OutcomesUniversity of Minnesota
  • Age ≥ 22 yrs
  • Level C5-S5
  • AIS A, B
  • ≥ 1 years
  • HAVE an existing and functional implanted spinal cord stimulator system that is FDA approved
  • NOT have current or anticipated need for opioid pain medication preventing participation in the rehabilitation program
  • NOT have received Botox injections in the last six months
Recruiting50NATechnologyArm/hand function
  • Surface Electromyography (sEMG)
10 years01 March 202330 January 20231
NCT03898804An Early Feasibility Study of the ReHAB SystemUniversity Hospitals Cleveland Medical CenterSingle Group Assignment
  • Age 22 - 65 yrs
  • Level C1-C8
  • AIS
  • ≥ 12 months
  • Be at least 12 months post onset of tetraplegia.
  • Not have an implanted stimulator (e.g. pacemaker or stimulators (of the spinal cord, deep brain, vagus nerve), cochlear implant, or defibrillator.
  • Not be ventilator dependent.
Recruiting12Not ApplicableTechnologyGeneral health
  • Grasp and Release Test (GRT)
  • Lawton Instrumental Activities of Daily Living scale (IADL)
13 months09 April 201902 April 20191